CIBC World Market
TXG icon

CIBC World Market’s 10x Genomics TXG Stock Holding History

CIBC World Market’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Sell
44,428
-26,474
-37% -$694K ﹤0.01% 892
2026
Q1 		$1.51M Buy
70,902
+7,053
+11% +$141K ﹤0.01% 824
2025
Q4 		$1.04M Buy
63,849
+1,385
+2% +$20.9K ﹤0.01% 930
2025
Q3 		$730K Buy
62,464
+23,543
+60% +$307K ﹤0.01% 1012
2025
Q2 		$451K Buy
+38,921
New +$355K ﹤0.01% 1080
2023
Q3 		– Sell
-11,383
Closed -$636K – 1287
2023
Q2 		$636K Sell
11,383
-61
-0.5% -$3.3K ﹤0.01% 869
2023
Q1 		$638K Buy
+11,444
New +$534K ﹤0.01% 851
2021
Q3 		– Sell
-2,072
Closed -$406K – 1442
2021
Q2 		$406K Buy
+2,072
New +$375K ﹤0.01% 1063

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIBC World Market's TXG Position: Q2 2026 in Review

CIBC World Market reduced its 10x Genomics (TXG) stake by 37% in Q2 2026, selling an estimated $694K and leaving 44,428 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #892.

CIBC World Market first reported a position in TXG in Q2 2021 and has held it in 8 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • CIBC World Market held 44,428 shares of 10x Genomics worth $1.7M as of Q2 2026.
  • CIBC World Market sold 26,474 10x Genomics shares in Q2 2026, an estimated $694K.
  • 10x Genomics made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #892 holding.
  • CIBC World Market first reported a position in 10x Genomics in Q2 2021 and has held it in 8 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.